Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240928063187N3Phase 3Completed
Phase 3, randomised, open-label trial of benzydamine in stomatitis (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Time of onset of oral mucositis, Duration of mucositis and 3 more. Started Dec 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240928063187N3.